Skip to main content
News Mass 12.2021
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Elvira Mass selected as EMBO Young Investigator junior scientist

Prof. Elvira Mass, developmental biologist at the LIMES Institute of the University of Bonn and member of the Cluster of Excellence ImmunoSensation2, will join the EMBO Young Investigator Program on 01.01.2022.

The EMBO Young Investigator Program supports selected young European scientists with outstanding achievements in the field of life sciences. The award is linked to a financial support of 15,000 €, which can be extended by up to 10,000 € per year. Prof. Elvira Mass and her team study the development and function of resident macrophages - phagocytes that are present in almost every tissue and, as part of the innate immune system, are an important part of the body's defense system.

Macrophages form the first line of defense against pathogens by ingesting them and breaking them down into their components (antigens). They present these antigens to other cells of the immune system and produce cytokines, which elicits an adapted immune response. According to recent scientific findings, however, resident macrophages have more tasks than previously thought: Beyond their classical role as scavenger cells, resident macrophages most likely significantly contribute to organ development. The team led by Prof. Elvira Mass investigates the function of resident macrophages in brain development. For this purpose, she recently received an ERC Starting Grant to investigate potential hazards of nanoplastics ingested with the food. The aim is to clarify whether the nanoplastic reaches our organs, whether it is taken up there, especially by macrophages, and whether it can induce or contribute to the development of neurological diseases in the long term (read more) .

However, the paradigm shift in the field of resident macrophages does not only apply to the function, but also to the origin of the phagocytes. Resident macrophages have been shown to develop in many organs during embryonic development and to self-renew in adult tissues under homeostatic conditions. Prof. Elvira Mass's team is interested in understanding the contribution of resident macrophages to homeostatic function during organ development, but also in the process of various disease conditions such as obesity or infectious diseases.

Born in present-day Kazakhstan, the Russian-German earned her PhD in Molecular Biomedicine at the University of Bonn, Germany, and returned to her alma mater after a three-year research stay at King's College London and Memorial Sloan-Kettering Cancer Center in New York. In 2017, she started the research group Developmental Biology of the Innate Immune System at LIMES Institute. In 2019, Elvira Mass was appointed W2 Professor at the University of Erlangen-Nürnberg, but was reappointed to the University of Bonn in 2020.

The scientific environment at the LIMES Institute and the Cluster of Excellence ImmunoSensation2 at the University of Bonn offers Prof. Elvira Mass an optimal environment for her research. This is based on the common scientific focus of the researchers at LIMES and other institutes united in the Cluster of Excellence ImmunoSensation2, as well as the connection to several national international research networks. With the EMBO Young Investigator award, this environment is now extended by a renowned network. In addition to direct financial support, Prof. Elvira Mass and her team will also benefit from training and mentoring opportunities linked to the award over the next 4 years.


Contact

Prof. Dr. Elvira Mass

Life & Medical Sciences Institute (Limes)

University of Bonn

Carl-Troll-Strasse 31

53115 Bonn

emass(at)uni-bonn.de

Related news

25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

News categories: Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry

Back to the news overview